218 related articles for article (PubMed ID: 21764586)
1. Prominent brainstem symptoms/signs in patients with neuromyelitis optica in a Taiwanese population.
Wang KC; Lee CL; Chen SY; Lin KH; Tsai CP
J Clin Neurosci; 2011 Sep; 18(9):1197-200. PubMed ID: 21764586
[TBL] [Abstract][Full Text] [Related]
2. Brain abnormalities in neuromyelitis optica.
Pittock SJ; Lennon VA; Krecke K; Wingerchuk DM; Lucchinetti CF; Weinshenker BG
Arch Neurol; 2006 Mar; 63(3):390-6. PubMed ID: 16533966
[TBL] [Abstract][Full Text] [Related]
3. Neuromyelitis optica preceded by brain demyelinating episode.
Amemiya S; Hamamoto M; Kumagai T; Ueda M; Katayama Y; Tanaka K
J Neuroimaging; 2009 Jul; 19(3):263-5. PubMed ID: 18681925
[TBL] [Abstract][Full Text] [Related]
4. Modifications of longitudinally extensive transverse myelitis and brainstem lesions in the course of neuromyelitis optica (NMO): a population-based, descriptive study.
Asgari N; Skejoe HP; Lillevang ST; Steenstrup T; Stenager E; Kyvik KO
BMC Neurol; 2013 Apr; 13():33. PubMed ID: 23566260
[TBL] [Abstract][Full Text] [Related]
5. Neuromyelitis optica antibodies in patients with severe optic neuritis in China.
Lai C; Tian G; Takahashi T; Liu W; Yang L; Zhang X
J Neuroophthalmol; 2011 Mar; 31(1):16-9. PubMed ID: 21150455
[TBL] [Abstract][Full Text] [Related]
6. Neuromyelitis optica with brainstem lesion mistaken for brainstem glioma. Case report.
Park KY; Ahn JY; Cho JH; Choi YC; Lee KS
J Neurosurg; 2007 Sep; 107(3 Suppl):251-4. PubMed ID: 17918537
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures.
Jarius S; Paul F; Franciotta D; Ruprecht K; Ringelstein M; Bergamaschi R; Rommer P; Kleiter I; Stich O; Reuss R; Rauer S; Zettl UK; Wandinger KP; Melms A; Aktas O; Kristoferitsch W; Wildemann B
J Neurol Sci; 2011 Jul; 306(1-2):82-90. PubMed ID: 21550068
[TBL] [Abstract][Full Text] [Related]
8. [Clinical features of NMO according to brain MRI findings].
Shimizu Y
Brain Nerve; 2010 Sep; 62(9):933-43. PubMed ID: 20844304
[TBL] [Abstract][Full Text] [Related]
9. Aquaporin-4 autoantibody: a neurogenic cause of anorexia and weight loss.
Fung EL; Tsung LL; Dale RC
Dev Med Child Neurol; 2012 Jan; 54(1):45-7. PubMed ID: 22171929
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese.
Matsuoka T; Matsushita T; Kawano Y; Osoegawa M; Ochi H; Ishizu T; Minohara M; Kikuchi H; Mihara F; Ohyagi Y; Kira J
Brain; 2007 May; 130(Pt 5):1206-23. PubMed ID: 17439988
[TBL] [Abstract][Full Text] [Related]
11. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression.
Pittock SJ; Weinshenker BG; Lucchinetti CF; Wingerchuk DM; Corboy JR; Lennon VA
Arch Neurol; 2006 Jul; 63(7):964-8. PubMed ID: 16831965
[TBL] [Abstract][Full Text] [Related]
12. Neuromyelitis optica (NMO) antibody positivity in patients with transverse myelitis and no visual manifestations.
Hamnik SE; Hacein-Bey L; Biller J; Gruener G; Jay W
Semin Ophthalmol; 2008; 23(3):191-200. PubMed ID: 18432545
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of long spinal cord lesions and anti-aquaporin 4 antibodies in neuromyelitis optica patients in Taiwan.
Wang KC; Tsai CP; Lee CL; Chen SY; Chen SJ
Eur Neurol; 2011; 65(2):99-104. PubMed ID: 21273778
[TBL] [Abstract][Full Text] [Related]
14. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.
Hinson SR; McKeon A; Fryer JP; Apiwattanakul M; Lennon VA; Pittock SJ
Arch Neurol; 2009 Sep; 66(9):1164-7. PubMed ID: 19752309
[TBL] [Abstract][Full Text] [Related]
15. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome.
Jarius S; Kleiter I; Ruprecht K; Asgari N; Pitarokoili K; Borisow N; Hümmert MW; Trebst C; Pache F; Winkelmann A; Beume LA; Ringelstein M; Stich O; Aktas O; Korporal-Kuhnke M; Schwarz A; Lukas C; Haas J; Fechner K; Buttmann M; Bellmann-Strobl J; Zimmermann H; Brandt AU; Franciotta D; Schanda K; Paul F; Reindl M; Wildemann B;
J Neuroinflammation; 2016 Nov; 13(1):281. PubMed ID: 27802825
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and treatment of neuromyelitis optica.
Wingerchuk DM
Neurologist; 2007 Jan; 13(1):2-11. PubMed ID: 17215722
[TBL] [Abstract][Full Text] [Related]
17. High-risk syndrome for neuromyelitis optica: a descriptive and comparative study.
Collongues N; Marignier R; Zéphir H; Blanc F; Vukusic S; Outteryck O; Fleury M; Ruet A; Borgel F; Thouvenot E; Moreau T; Defer G; Derache N; Pelletier J; Audoin B; Debouverie M; Labauge P; Gout O; Camu W; Brassat D; Brochet B; Vermersch P; Confavreux C; de Seze J
Mult Scler; 2011 Jun; 17(6):720-4. PubMed ID: 21239412
[TBL] [Abstract][Full Text] [Related]
18. Relationship between neuromyelitis optica-IgG status and spinal cord magnetic resonance imaging in patients with neuromyelitis optica.
Zhong XN; Wang HH; Bao J; Li R; Long YM; Lu ZQ; Dai YQ; Qiu W; Hu XQ
Chin Med J (Engl); 2012 Jan; 125(2):270-4. PubMed ID: 22340558
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.
Jarius S; Paul F; Franciotta D; Waters P; Zipp F; Hohlfeld R; Vincent A; Wildemann B
Nat Clin Pract Neurol; 2008 Apr; 4(4):202-14. PubMed ID: 18334978
[TBL] [Abstract][Full Text] [Related]
20. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.
Misu T; Fujihara K; Kakita A; Konno H; Nakamura M; Watanabe S; Takahashi T; Nakashima I; Takahashi H; Itoyama Y
Brain; 2007 May; 130(Pt 5):1224-34. PubMed ID: 17405762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]